Quercetin up-regulates paraoxonase 1 gene expression with concomitant protection against LDL oxidation

Biochemical and Biophysical Research Communications

Volumn 379, Issue 4, 2009, Pages 1001-1004

  Gong, Maokai ^a,b   Garige, Mamatha ^a,b   Varatharajalu, Ravi ^a,b   Marmillot, Philippe ^a,b   Gottipatti, Chandra ^a,b   Leckey, Leslie Castillo ^a,b   Lakshman, Raj M ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

HCTL; LDL oxidation; PON1; Quercetin

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; HOMOCYSTEINE; HOMOCYSTEINE THIOLACTONASE; LOW DENSITY LIPOPROTEIN; QUERCETIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; MALE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; CARBOXYLIC ESTER HYDROLASES; CHOLESTEROL, LDL; COPPER SULFATE; GENE EXPRESSION; LIVER; MALE; OXIDATION-REDUCTION; QUERCETIN; RATS; RATS, WISTAR;

RATTUS;

EID: 58949085340     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.01.015     Document Type: Article

References (34)

1. Aldridge W.N. Serum esterase II: an enzyme hydrolyzing diethyl p-nitophenylphosphate (E600) and its identity with the A-esterase of mammalian sera. Biochem. J. 53 (1953) 117-124
2. Blatter M.C., James R.W., Messmer S., Barja F., and Pometta D. Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase. Eur. J. Biochem. 211 3 (1993) 871-879
3. Rao M.N., Liu Q.H., Marmillot P., Seeff L.B., Strader D.B., and Lakshman M.R. High-density lipoproteins from human alcoholics exhibit impaired reverse cholesterol transport function. Metabolism 49 11 (2000) 1406-1410
4. Mackness M.I., Abbott C., Arrol S., and Durrington P.N. The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation. Biochem. J. 294 Pt 3 (1993) 829-834
5. Watson A.D., Berliner J.A., Hama S.Y., La Du B.N., Faull K.F., Fogelman A.M., and Navab M. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J. Clin. Invest. 96 6 (1995) 2882-2891
6. Aviram M., and Rosenblat M. Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic. Biol. Med. 37 9 (2004) 1304-1316
7. Mackness M.I., Arrol S., Abbott C.A., and Durrington P.N. Is paraoxonase related to atherosclerosis. Chem. Biol. Interact. 87 1-3 (1993) 161-171
8. Jakubowski H., Zhang L., Bardeguez A., and Aviv A. Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implications for atherosclerosis. Circ. Res. 87 1 (2000) 45-51
9. Shih D.M., Gu L., Xia Y.R., Navab M., Li W.F., Hama S., Castellani L.W., Furlong C.E., Costa L.G., Fogelman A.M., and Lusis A.J. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394 6690 (1998) 284-287
10. Mackness .M., Durrington P., and Mackness B. Paraoxonase 1 activity, concentration and genotype in cardiovascular disease. Curr. Opin. Lipidol. 15 4 (2004) 399-404
11. Lawlor D.A., Day I.N., Gaunt T.R., Hinks L.J., Briggs P.J., Kiessling M., Timpson N., Smith G.D., and Ebrahim S. The association of the PON1 Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a meta-analysis. BMC Genet. 235 1 (2004) 17
12. Aynacioglu A.S., and Kepekci Y. The human paraoxonase Gln-Argl92 (Q/R) polymorphism in turkish patients with coronary artery disease. Int. J. Cardiol. 74 1 (2000) 33-37
13. Turban S., Fuentes F., Ferlic L., Brugada R., Gotto A.M., Ballantyne C.M., and Marian A.J. A prospective study of paraoxonase gene Q/R192 polymorphism and severity, progression and regression of coronary atherosclerosis, plasma lipid levels, clinical events and response to fluvastatin. Atherosclerosis 154 3 (2001) 633-640
14. Mackness M., and Mackness B. Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?. Free Radic. Biol. Med. 37 9 (2004) 1317-1323
15. Rozenberg O., Shih D.M., and Aviram M. Human serum paraoxonase 1 decreases macrophage cholesterol biosynthesis: possible role for its phospholipase-A2-like activity and lysophosphatidylcholine formation. Arterioscler. Thromb. Vasc. Biol. 23 3 (2003) 461-467
16. Marmillot P., Rao M.N., Liu Q.H., Chirtel S.J., and Lakshman M.R. Effect of dietary omega-3 fatty acids and chronic ethanol consumption on reverse cholesterol transport in rats. Metabolism 49 4 (2000) 508-512
17. Rosenblat M., Vaya J., Shih D.M., and Aviram M. Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine. Atherosclerosis 179 1 (2005) 69-77
18. Rozenberg O., Shih D.M., and Aviram M. Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice. Atherosclerosis 181 1 (2005) 9-18
19. Hayek T., Fuhrman B., Vaya J., Rosenblat M., Belinky P., Coleman R., Elis A., and Aviram M. Reduced progression of atherosclerosis in apoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 2744-2752
20. De Whalley C.V., Rankin S.M., Hoult J.R., Jessup W., and Leake D.S. Flavonoids inhibit the antioxidative modification of low density lipoproteins. Biochem. Pharmacol. 39 (1990) 1743-1749
21. Hollman P.C., Hertgo M.G., and Katan M.B. Role of dietary flavonoids in protection against cancer and coronary heart disease. Biochem. Soc. Trans. 24 (1996) 785-789
22. Lieber C.S., and DeCarli L.M. The feeding of alcohol in liquid diets: two decades of applications and 1982 update. Alcohol Clin. Exp. Res. 6 4 (1982) 523-531
23. Rao M.N., Marmillot P., Gong M., Palmer D.A., Seeff L.B., Strader D.B., and Lakshman M.R. Light, but not heavy alcohol drinking, stimulates paraoxonase by upregulating liver mRNA in rats and humans. Metabolism 52 (2003) 1287-1294
24. Lakshman M.R., Gottipati C.S., Narasimhan S.J., Munoz J., Marmillot P., and Nylon E.S. Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus. Metabolism 55 9 (2006) 1201-1206
25. Jakubowski H. Calcium-dependent human serum homocysteine thiolactone hydrolase protective mechanism against protein n-homocysteinylation. J. Biol. Chem. 275 (2000) 3957-3962
26. Baernstein H.D. A modification of the method for determining methionine in proteins. J. Biol. Chem. 106 (1934) 451-456
27. Jakubowski H. Translational incorporation of S-nitrosohomocysteine into protein. J. Biol. Chem. 275 29 (2000) 21813-21816
28. Gidez L.I., Miller G.J., Burstein M., Slagle S., and Eder H.A. Separation and quantitation of subclasses of human high density lipoproteins by a simple precipitation procedure. J. Lipid Res. 23 (1982) 1206-1220
29. Burstein M., Scholnick H.R., and Morfin R. Rapid method for the isolation of lipoproteins from human serum. J. Lipid Res. 11 6 (1970) 583-595
30. Jakubowski H. Metabolism of homocysteine thiolactone in human cell cultures. J. Biol. Chem. 272 (1997) 1935-1942
31. Deakin S., Leviev I., Guernier S., and James R.W. Simvastatin modulates expression of the PON1 gene and increases serum paraoxonase: a role for sterol regulatory element-binding protein-2. Arterioscler. Thromb. Vasc. Biol. 23 11 (2003) 2083-2089
32. Osaki F., Ikeda Y., Suehiro T., Ota K., Tsuzura S., Arii K., Kumon Y., and Hashimoto K. Roles of Sp1 and protein kinase C in regulation of human serum paraoxonase 1 (PON1) gene transcription in HepG2 cells. Atherosclerosis 176 2 (2004) 279-287
33. Gouedard C., Koum-Besson N., Barouki R., and Morel Y. Opposite regulation of the human paraoxonase-1 gene PON-1 by fenofibrate and statins. Mol. Pharmacol. 63 4 (2003) 945-956
34. Gouedard C., Barouki R., and Morel Y. Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism. Mol. Cell Biol. 24 12 (2004) 5209-5222